Cargando…

Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics

Weight gain and metabolic syndrome are common side effects of second-generation antipsychotics and carry significant health consequences both in childhood and into adulthood. This review highlights evidence-based, non-pharmacologic interventions to assist in the management of these side effects. Suc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rice, Jessie, Ramtekkar, Ujjwal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564042/ https://www.ncbi.nlm.nih.gov/pubmed/32824428 http://dx.doi.org/10.3390/medsci8030034

Ejemplares similares

Metabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management
por: Krill, Rebecca A, et al.
Publicado: (2014)

Association of Lithium and Second-Generation Antipsychotics with Neurocognition in Youth with Bipolar Disorder
por: Jiang, Xinyue, et al.
Publicado: (2022)

Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
por: Grajales, Diana, et al.
Publicado: (2019)

Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists
por: Pisano, Simone, et al.
Publicado: (2016)

DSM-5 Changes in Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: Implications for Comorbid Sleep Issues
por: Ramtekkar, Ujjwal P.
Publicado: (2017)

Youth, Caregiver, and Prescriber Experiences of Antipsychotic-Related Weight Gain
por: Murphy, Andrea Lynn, et al.
Publicado: (2013)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Iron, Magnesium, Vitamin D, and Zinc Deficiencies in Children Presenting with Symptoms of Attention-Deficit/Hyperactivity Disorder
por: Villagomez, Amelia, et al.
Publicado: (2014)

Relationship between Sleep and Psychosis in the Pediatric Population: A Brief Review
por: Bordoloi, Meelie, et al.
Publicado: (2018)

Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics
por: Gautam, Shiv, et al.
Publicado: (2011)

Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome
por: Skonieczna-Żydecka, Karolina, et al.
Publicado: (2018)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Prevalence and Management of Metabolic Syndrome in Adult Psychiatric Patients Receiving Second-Generation Antipsychotics at Sheikh Khalifa Medical City
por: Mohammed, Wadha, et al.
Publicado: (2022)

Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis
por: Poojari, Pooja Gopal, et al.
Publicado: (2023)

Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
por: Fang, Xinyu, et al.
Publicado: (2019)

The Effect of Long-Term Second-Generation Antipsychotics Use on the Metabolic Syndrome Parameters in Jordanian Population
por: Abo Alrob, Osama, et al.
Publicado: (2019)

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
por: Belvederi Murri, Martino, et al.
Publicado: (2015)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Is obstructive sleep apnea the missing link between metabolic syndrome and second-generation antipsychotics: Preliminary study
por: Rohatgi, Rupali, et al.
Publicado: (2018)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy
por: Jauhar, Sameer, et al.
Publicado: (2019)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
por: Płaza, Olga, et al.
Publicado: (2022)

Antipsychotic prescribing in dementia
por: McLoughlin, James, et al.
Publicado: (2021)

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study
por: Hirsch, Lauren, et al.
Publicado: (2018)

Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy
por: Ostuzzi, Giovanni, et al.
Publicado: (2018)

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
por: Alkhadhari, Sulaiman, et al.
Publicado: (2015)

CHILD AND ADOLESCENT TELE-PARTIAL HOSPITALIZATION PROGRAMS (TELE-PHP): OPPORTUNITIES AND CHALLENGES
por: Baweja, Raman, et al.
Publicado: (2021)

Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients
por: Misiak, Błażej, et al.
Publicado: (2014)

Impact of SGLT2 inhibitors on metabolic status in patients with psychiatric disorders undergoing treatment with second‑generation antipsychotics (Review)
por: Vasiliu, Octavian
Publicado: (2023)

Arterial Stiffness in Patients Taking Second-generation Antipsychotics
por: Fındıklı, Ebru, et al.
Publicado: (2016)

Using Practice Facilitation to Improve Depression Management in Rural Pediatric Primary Care Practices
por: Baum, Rebecca A., et al.
Publicado: (2020)

First-generation vs second-generation antipsychotic drugs: The ongoing saga
por: Gupta, Sumeet
Publicado: (2010)

Critical Review of the Use of Second-Generation Antipsychotics in Obsessive–Compulsive and Related Disorders
por: Kim, Dongmi, et al.
Publicado: (2018)

The impact of prescribed psychotropics on youth
por: Lakhan, Shaheen E, et al.
Publicado: (2007)

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
por: Montemagni, Cristiana, et al.
Publicado: (2016)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Telebehavioral Health: Workforce, Access, and Future Implications
por: Reese, Jennifer B., et al.
Publicado: (2022)

Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects
por: Rognoni, Carla, et al.
Publicado: (2021)

Pharmacist Involvement in Population Health Management for a Pediatric Managed Medicaid Accountable Care Organization
por: Kuhn, Catherine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2e11m970tnsqr69rcl8m34k1l2